epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Aveeno Eczema Therapy Moisturizing Cream
    colloidal oatmeal topical
  • remove clarithromycin
    generic
  • remove Combivent
    ipratropium bromide/ albuterol inhaled
  • remove Effexor
    venlafaxine
  • remove Kesimpta
    ofatumumab

multicheck MultiCheck Results - 3 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face clarithromycin (generic) + Combivent (ipratropium bromide/ albuterol inhaled)

Monitor/Modify Tx


clarithromycin + albuterol inhaled

monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

Smiley face Smiley face clarithromycin (generic) + Effexor (venlafaxine)

Monitor/Modify Tx


clarithromycin + venlafaxine

monitor ECG: combo may incr. venlafaxine levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects (hepatic metabolism inhibited, additive effects)

Smiley face Smiley face Combivent (ipratropium bromide/ albuterol inhaled) + Effexor (venlafaxine)

Monitor/Modify Tx


albuterol inhaled + venlafaxine

monitor BP, HR: combo may incr. risk of HTN, other cardiovascular adverse effects (additive effects)

Additional Considerations

Smiley face Smiley face venlafaxine in Effexor

add MAO inhibitor to Interaction Check if recent (14 days) use

Smiley face Smiley face ofatumumab in Kesimpta

myelosuppression associated with higher, more frequent doses used for cancer chemotherapy, lower risk with MS doses

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback Cookie Preferences
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information